Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 20/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3234546 | 0.92 | P2RY12 (0.83) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3230357 | 0.91 | P2RY12 (0.73) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3220360 | 0.90 | P2RY12 (0.85) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3327261 | 0.90 | P2RY12 (0.72) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3324560 | 0.90 | P2RY12 (1.00) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3230320 | 0.88 | P2RY12 (0.81) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3327520 | 0.88 | P2RY12 (0.86) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3225637 | 0.86 | P2RY12 (0.87) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3223687 | 0.86 | P2RY12 (0.87) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL3326837 | 0.85 | P2RY12 (0.86) | P2RY12CYP2C9CYP3A4CHRM2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010005384-A1 | KETONE PYRIDINE ANALOGUES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS | ASTRAZENECA AB (SE) | 2010-01-14 | — | — | WO | disclosed |